Editor Profile

Mary E. Wilson, MD

Associate Editor

About the NEJM Journal Watch Infectious Diseases Board

Mary E. Wilson, MD, is Visiting Professor of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco and Adjunct Professor of Global Health and Population, Harvard School of Public Health. Her academic interests include tuberculosis, ecology of infections, emergence of new infections, determinants of disease distribution, travel medicine, and vaccines. She has served on the Advisory Committee for Immunization Practices of the CDC and the Academic Advisory Committee for the National Institute of Public Health in Mexico. Dr. Wilson has been writing for NEJM Journal Watch Infectious Diseases since the publication was launched in 1998.


Editorial boards

UptoDate; Clinical Infectious Diseases; RSTMH International Health; Infectious Diseases in Clinical Practice; Travel Medicine and Infectious Diseases

Summaries by Mary Wilson

  • August 20, 2014

    Chikungunya Vaccine Immunogenic and Safe in a Phase I Trial

    1. Mary E. Wilson, MD

    In an open-label trial among adults, a viruslike particle–based chikungunya vaccine induced durable neutralizing antibodies and was well tolerated.

  • July 30, 2014

    Drug-Resistant Malaria Is Spreading, but a New Agent Shows Promise

    1. Mary E. Wilson, MD

    While artemisinin-resistant falciparum malaria spreads in Southeast Asia, a new synthetic spiroindolone analogue has cleared vivax and falciparum parasites in a phase II study.

  • July 24, 2014

    Tetravalent Dengue Vaccine Efficacious for Children in Asia

    1. Mary E. Wilson, MD

    A recombinant, live, attenuated dengue vaccine given in three doses to healthy children in Asia was efficacious against virologically confirmed dengue infections.

  • July 14, 2014

    Model Predicts Burden of Childhood TB

    1. Mary E. Wilson, MD

    The predicted burden of pediatric tuberculosis is substantially greater than has been suggested by previous estimates.

  • July 8, 2014

    Vivax Malaria: Not Always Benign

    1. Mary E. Wilson, MD

    Among vivax malaria patients in coastal Peru in 2008–2009, 0.4% were critically ill — more than half of them with severe anemia.

  • May 19, 2014

    Brazil: Identifying World Cup Cities at Highest Risk for Dengue

    1. Mary E. Wilson, MD

    A predictive model based on real-time seasonal climate forecasts and dengue incidence data can provide early warnings to World Cup cities at highest risk for outbreaks.